Nosopharm
Research and development of anti-infective drugs
Nosopharm has raised €2.4M across 1 funding round from 3 investors, most recently a Early VC round in Nov 2020. Based in Nimes, France; founded 2009; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€2.4M
€2,400,000
Funding rounds
1
Investors
3
distinct backers
Active since
2020-11
latest 2020-11
Funding by year
EUR raised per yearNosopharm — funding by year — interactive chart.
Data table
| Nosopharm — funding by year | |
|---|---|
| 2020 | €2.4M |
Signals
High confidenceRaise-next likelihood8
base rate 42% for Early VC
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-11-01 | Early VC | €2.4M | Alto Invest,Auriga Partners,Kreaxi | View deal → |
Investors
3Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData